{
    "Trade/Device Name(s)": [
        "Hemochron Signature Elite",
        "Hemochron\u2122 Signature Elite",
        "HemochronTM Signature Elite"
    ],
    "Submitter Information": "Accriva Diagnostics, Inc.",
    "510(k) Number": "K193041",
    "Predicate Device Reference 510(k) Number(s)": [
        "K050016"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JPA"
    ],
    "Summary Letter Date": "October 30, 2019",
    "Summary Letter Received Date": "October 31, 2019",
    "Submission Date": "October 30, 2019",
    "Regulation Number(s)": [
        "21 CFR 864.5425"
    ],
    "Regulation Name(s)": [
        "Multipurpose System For In Vitro Coagulation Studies"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "Activated Clotting Time (ACT+ and ACT-LR)",
        "Activated Partial Thromboplastin Time (APTT and APTT Citrate)",
        "Prothrombin Time (PT and PT Citrate)"
    ],
    "Specimen Type(s)": [
        "Fresh Whole Blood",
        "Citrated Whole Blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Hemochron Signature Elite"
    ],
    "Method(s)/Technology(ies)": [
        "Mechanical-optical clot detection"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Instrument",
        "System",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for Hemochron Signature Elite point-of-care coagulation analyzer with updated software Version 2.4",
    "Indications for Use Summary": "Performs individual point-of-care coagulation tests (ACT, APTT, PT) on fresh or citrated whole blood using disposable cuvettes for in vitro diagnostic use by professionals.",
    "fda_folder": "Hematology"
}